Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World Practice

Data regarding chemotherapy options and benefits in older women with early triple-negative breast cancer (TNBC) are limited. Our study aimed to assess the effects of adjuvant chemotherapy on recurrence-free survival (RFS), breast cancer-specific survival (BCSS), and overall survival (OS) rates in el...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiu, Meng, Zhang, Pin, Li, Qing, Yuan, Peng, Wang, Jiayu, Luo, Yang, Ma, Fei, Cai, Ruigang, Fan, Ying, Li, Qiao, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097590/
https://www.ncbi.nlm.nih.gov/pubmed/35574419
http://dx.doi.org/10.3389/fonc.2022.867583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097590/
https://www.ncbi.nlm.nih.gov/pubmed/35574419
http://dx.doi.org/10.3389/fonc.2022.867583

Ejemplares similares